402 related articles for article (PubMed ID: 27818384)
1. Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy.
Laurent C; Dorothée G; Hunot S; Martin E; Monnet Y; Duchamp M; Dong Y; Légeron FP; Leboucher A; Burnouf S; Faivre E; Carvalho K; Caillierez R; Zommer N; Demeyer D; Jouy N; Sazdovitch V; Schraen-Maschke S; Delarasse C; Buée L; Blum D
Brain; 2017 Jan; 140(1):184-200. PubMed ID: 27818384
[TBL] [Abstract][Full Text] [Related]
2. The GABAergic septohippocampal connection is impaired in a mouse model of tauopathy.
Soler H; Dorca-Arévalo J; González M; Rubio SE; Ávila J; Soriano E; Pascual M
Neurobiol Aging; 2017 Jan; 49():40-51. PubMed ID: 27743524
[TBL] [Abstract][Full Text] [Related]
3. MRNA Levels of ACh-Related Enzymes in the Hippocampus of THY-Tau22 Mouse: A Model of Human Tauopathy with No Signs of Motor Disturbance.
García-Gómez BE; Fernández-Gómez FJ; Muñoz-Delgado E; Buée L; Blum D; Vidal CJ
J Mol Neurosci; 2016 Apr; 58(4):411-5. PubMed ID: 26697857
[TBL] [Abstract][Full Text] [Related]
4. Brain network remodelling reflects tau-related pathology prior to memory deficits in Thy-Tau22 mice.
Degiorgis L; Karatas M; Sourty M; Faivre E; Lamy J; Noblet V; Bienert T; Reisert M; von Elverfeldt D; Buée L; Blum D; Boutillier AL; Armspach JP; Blanc F; Harsan LA
Brain; 2020 Dec; 143(12):3748-3762. PubMed ID: 33184651
[TBL] [Abstract][Full Text] [Related]
5. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
6. Exacerbation of C1q dysregulation, synaptic loss and memory deficits in tau pathology linked to neuronal adenosine A2A receptor.
Carvalho K; Faivre E; Pietrowski MJ; Marques X; Gomez-Murcia V; Deleau A; Huin V; Hansen JN; Kozlov S; Danis C; Temido-Ferreira M; Coelho JE; Mériaux C; Eddarkaoui S; Gras SL; Dumoulin M; Cellai L; ; Landrieu I; Chern Y; Hamdane M; Buée L; Boutillier AL; Levi S; Halle A; Lopes LV; Blum D
Brain; 2019 Nov; 142(11):3636-3654. PubMed ID: 31599329
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology.
Belarbi K; Burnouf S; Fernandez-Gomez FJ; Laurent C; Lestavel S; Figeac M; Sultan A; Troquier L; Leboucher A; Caillierez R; Grosjean ME; Demeyer D; Obriot H; Brion I; Barbot B; Galas MC; Staels B; Humez S; Sergeant N; Schraen-Maschke S; Muhr-Tailleux A; Hamdane M; Buée L; Blum D
Neurobiol Dis; 2011 Aug; 43(2):486-94. PubMed ID: 21569847
[TBL] [Abstract][Full Text] [Related]
8. Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy.
Blair LJ; Frauen HD; Zhang B; Nordhues BA; Bijan S; Lin YC; Zamudio F; Hernandez LD; Sabbagh JJ; Selenica ML; Dickey CA
Acta Neuropathol Commun; 2015 Jan; 3():8. PubMed ID: 25775028
[TBL] [Abstract][Full Text] [Related]
9. Passive immunization with phospho-tau antibodies reduces tau pathology and functional deficits in two distinct mouse tauopathy models.
Sankaranarayanan S; Barten DM; Vana L; Devidze N; Yang L; Cadelina G; Hoque N; DeCarr L; Keenan S; Lin A; Cao Y; Snyder B; Zhang B; Nitla M; Hirschfeld G; Barrezueta N; Polson C; Wes P; Rangan VS; Cacace A; Albright CF; Meredith J; Trojanowski JQ; Lee VM; Brunden KR; Ahlijanian M
PLoS One; 2015; 10(5):e0125614. PubMed ID: 25933020
[TBL] [Abstract][Full Text] [Related]
10. Aging and high-fat diet feeding lead to peripheral insulin resistance and sex-dependent changes in brain of mouse model of tau pathology THY-Tau22.
Kacířová M; Železná B; Blažková M; Holubová M; Popelová A; Kuneš J; Šedivá B; Maletínská L
J Neuroinflammation; 2021 Jun; 18(1):141. PubMed ID: 34158075
[TBL] [Abstract][Full Text] [Related]
11. Tau-targeting passive immunization modulates aspects of pathology in tau transgenic mice.
Ittner A; Bertz J; Suh LS; Stevens CH; Götz J; Ittner LM
J Neurochem; 2015 Jan; 132(1):135-45. PubMed ID: 25041093
[TBL] [Abstract][Full Text] [Related]
12. Tauopathy contributes to synaptic and cognitive deficits in a murine model for Alzheimer's disease.
Stancu IC; Ris L; Vasconcelos B; Marinangeli C; Goeminne L; Laporte V; Haylani LE; Couturier J; Schakman O; Gailly P; Pierrot N; Kienlen-Campard P; Octave JN; Dewachter I
FASEB J; 2014 Jun; 28(6):2620-31. PubMed ID: 24604080
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology.
Laurent C; Eddarkaoui S; Derisbourg M; Leboucher A; Demeyer D; Carrier S; Schneider M; Hamdane M; Müller CE; Buée L; Blum D
Neurobiol Aging; 2014 Sep; 35(9):2079-90. PubMed ID: 24780254
[TBL] [Abstract][Full Text] [Related]
14. Brain insulin response and peripheral metabolic changes in a Tau transgenic mouse model.
Leboucher A; Ahmed T; Caron E; Tailleux A; Raison S; Joly-Amado A; Marciniak E; Carvalho K; Hamdane M; Bantubungi K; Lancel S; Eddarkaoui S; Caillierez R; Vallez E; Staels B; Vieau D; Balschun D; Buee L; Blum D
Neurobiol Dis; 2019 May; 125():14-22. PubMed ID: 30665005
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.
Schindowski K; Bretteville A; Leroy K; Bégard S; Brion JP; Hamdane M; Buée L
Am J Pathol; 2006 Aug; 169(2):599-616. PubMed ID: 16877359
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology.
Burlot MA; Braudeau J; Michaelsen-Preusse K; Potier B; Ayciriex S; Varin J; Gautier B; Djelti F; Audrain M; Dauphinot L; Fernandez-Gomez FJ; Caillierez R; Laprévote O; Bièche I; Auzeil N; Potier MC; Dutar P; Korte M; Buée L; Blum D; Cartier N
Hum Mol Genet; 2015 Nov; 24(21):5965-76. PubMed ID: 26358780
[TBL] [Abstract][Full Text] [Related]
17. P2X7-deficiency improves plasticity and cognitive abilities in a mouse model of Tauopathy.
Carvalho K; Martin E; Ces A; Sarrazin N; Lagouge-Roussey P; Nous C; Boucherit L; Youssef I; Prigent A; Faivre E; Eddarkaoui S; Gauvrit T; Vieau D; Boluda S; Huin V; Fontaine B; Buée L; Delatour B; Dutar P; Sennlaub F; Guillonneau X; Blum D; Delarasse C;
Prog Neurobiol; 2021 Nov; 206():102139. PubMed ID: 34391810
[TBL] [Abstract][Full Text] [Related]
18. Vectored Intracerebral Immunization with the Anti-Tau Monoclonal Antibody PHF1 Markedly Reduces Tau Pathology in Mutant Tau Transgenic Mice.
Liu W; Zhao L; Blackman B; Parmar M; Wong MY; Woo T; Yu F; Chiuchiolo MJ; Sondhi D; Kaminsky SM; Crystal RG; Paul SM
J Neurosci; 2016 Dec; 36(49):12425-12435. PubMed ID: 27927959
[TBL] [Abstract][Full Text] [Related]
19. NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model.
Burnouf S; Martire A; Derisbourg M; Laurent C; Belarbi K; Leboucher A; Fernandez-Gomez FJ; Troquier L; Eddarkaoui S; Grosjean ME; Demeyer D; Muhr-Tailleux A; Buisson A; Sergeant N; Hamdane M; Humez S; Popoli P; Buée L; Blum D
Aging Cell; 2013 Feb; 12(1):11-23. PubMed ID: 23082852
[TBL] [Abstract][Full Text] [Related]
20. Loss of forebrain BIN1 attenuates hippocampal pathology and neuroinflammation in a tauopathy model.
Ponnusamy M; Wang S; Yuksel M; Hansen MT; Blazier DM; McMillan JD; Zhang X; Dammer EB; Collier L; Thinakaran G
Brain; 2023 Apr; 146(4):1561-1579. PubMed ID: 36059072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
